首页 > 市场调查报告书 > 医疗设备

生技设备 3D列印

市场调查报告书

商品编码

1547587

全球 3D 生物列印市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global 3D Bioprinting Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 127 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计全球 3D 生物列印市场需求将从 2023 年的 27.9 亿美元增至 2032 年的近 83.8 亿美元，2024-2032 年研究期间复合年增长率为 13.02%。

3D生物列印是一种先进技术，涉及生物材料、细胞和生长因子的逐层沉积，以创建模仿生物组织和器官的三维结构。它能够精确製造具有可自订属性（例如形状、尺寸和成分）的复杂生物结构，适用于组织工程、再生医学和药物测试。它承诺透过提供个人化的组织和器官替代品、减少器官移植的需求以及解决捐赠器官的短缺问题，彻底改变医疗保健领域。该领域的研究重点是改进列印技术、生物墨水配方和组织成熟过程，以增强生物列印结构的功能和可行性。

市场动态

推动 3D 生物列印市场的因素包括对个人化医疗的需求不断增长、生物列印技术的进步以及慢性病和器官衰竭的流行。个人化医疗可根据患者的个别需求客製化治疗方案，透过 3D 生物列印可以创建患者特定的组织和器官，从而显着受益。这种方法在再生医学和器官移植中特别有价值，因为捐赠器官的短缺仍然是一个关键问题。改进的生物墨水和更精确的印刷技术等进步也在推动市场向前发展。这些创新允许生产具有更高准确性和功能的复杂组织结构，从而增强生物列印产品的治疗潜力。此外，糖尿病和心血管疾病等慢性疾病的成长增加了对组织工程解决方案的需求，从而推动了3D生物列印市场的发展。研究机构和生物列印公司之间的合作促进创新并加速生物列印组织和器官的商业化，进一步推动市场成长。然而，道德问题和监管挑战可能会阻碍未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球 3D 生物列印市场的各个细分市场进行了包容性评估。 3D 生物列印产业的成长和趋势为本研究提供了整体方法。

市场区隔

3D 生物列印市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

依技术

磁浮
基于喷墨
基于注射器
基于雷射
其他的

按申请

医疗（组织和器官生成、药丸、义肢和植入物、其他）
牙科
生物感测器
消费者/个人产品测试
生物墨水
食品和动物产品

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲 3D 生物列印市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 3D生物列印市场的主要参与者包括Envisiontec Inc.、Organovo Holdings Inc.、Inventia Life Science PTY LTD、Poietis、Vivax Bio LLC、Allevi、Cyfuse Biomedical KK、3D Bioprinting Solutions、Celllink Global、Regemat 3D SL。的整体看法，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

Covid-19 爆发的影响分析
- 对生产的直接影响
- 供应炼和市场扰乱
- 对公司和金融市场的财务影响
按生产、进口、出口和需求分類的 COVID-19 影响分析
市场：COVID-19 前 V/S 后
冠状病毒 (COVID-19) 疫情的预期影响
COVID-19：微观和宏观因素分析

第 6 章：全球 3D 生物列印市场分析：按技术分类

依技术概述
历史和预测数据
依技术分析
磁浮市场：按地区
喷墨市场：按地区划分
基于注射器的市场：按地区
雷射市场：按地区划分
其他市场：按地区

第 7 章：全球 3D 生物列印市场分析：按应用分类

概述：按应用
历史和预测数据
分析：按应用
医疗市场：按地区
牙科市场：按地区
生物感测器市场：按地区
消费者/个人产品测试市场：按地区
生物墨水市场：按地区
食品和动物产品市场：按地区

第 8 章：全球 3D 生物列印市场分析：按地理位置

区域展望
介绍
北美洲
- 概览、历史和预测数据
- 北美按细分市场
- 北美洲：依国家分类
- 美国
- 加拿大
- 墨西哥
欧洲
- 概览、历史和预测数据
- 欧洲按细分市场
- 欧洲 : 按国家/地区
- 英国
- 法国
- 德国
- 义大利
- 俄罗斯
- 欧洲其他地区
亚太地区
- 概览、历史和预测数据
- 亚太地区（按细分市场）
- 亚太地区：依国家分类
- 中国
- 印度
- 日本
- 韩国
- 澳洲
- 亚太其他地区
拉丁美洲
- 概览、历史和预测数据
- 拉丁美洲按细分市场
- 拉丁美洲 : 依国家分类
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 拉丁美洲其他地区
中东和非洲
- 概览、历史和预测数据
- 中东和非洲（按细分市场）
- 中东和非洲：按国家/地区
- 沙乌地阿拉伯
- 阿联酋
- 以色列
- 南非
- 中东和非洲其他地区

第 9 章：3D 生物列印公司的竞争格局

3D生物列印市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Envisiontec, Inc.

公司概况
产品
最新动态

Inventia Life Science PTY LTD

公司概况
产品
最新动态

Organovo Holdings, Inc.

公司概况
产品
最新动态

Vivax Bio

公司概况
产品
最新动态

公司概况
产品
最新动态

3D Bioprinting Solutions

公司概况
产品
最新动态

Regemat 3D SL

公司概况
产品
最新动态

Poietis

公司概况
产品
最新动态

AlleviCyfuse Biomedical KK

公司概况
产品
最新动态

Cellink Global

公司概况
产品
最新动态

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR11214611

The global demand for 3D Bioprinting Market is presumed to reach the market size of nearly USD 8.38 Billion by 2032 from USD 2.79 Billion in 2023 with a CAGR of 13.02% under the study period 2024-2032.

3D bioprinting is an advanced technique that involves the layer-by-layer deposition of biomaterials, cells, and growth factors to create three-dimensional structures mimicking biological tissues and organs. It enables the precise fabrication of complex biological constructs with customizable properties, such as shape, size, and composition, for applications in tissue engineering, regenerative medicine, and drug testing. It promises to revolutionize healthcare by providing personalized tissue and organ replacements, reducing the need for organ transplants, and addressing the shortage of donor organs. Research in this field focuses on improving printing techniques, bioink formulations, and tissue maturation processes to enhance the functionality and viability of bioprinted constructs.

MARKET DYNAMICS

Factors driving the 3D bioprinting market include the increasing demand for personalized medicine, advancements in bioprinting technologies, and the spurring prevalence of chronic diseases and organ failures. Personalized medicine, which tailors treatments to individual patient needs, benefits significantly from 3D bioprinting by enabling the creation of patient-specific tissues and organs. This approach is particularly valuable in regenerative medicine and organ transplantation, where the shortage of donor organs remains a critical issue. Advancements, such as improved bioinks and more precise printing techniques, are also propelling the market forward. These innovations allow for the production of complex tissue structures with greater accuracy and functionality, enhancing the therapeutic potential of bioprinted products. Furthermore, the growth in chronic diseases such as diabetes & cardiovascular diseases increases the demand for tissue engineering solutions, thereby boosting the 3D bioprinting market. Collaborations between research institutions and bioprinting companies foster innovation and accelerate the commercialization of bioprinted tissues and organs, further driving the market growth. However, ethical concerns and regulatory challenges may hinder the market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of 3D Bioprinting. The growth and trends of 3D Bioprinting industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the 3D Bioprinting market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Magnetic Levitation
Inkjet-based
Syringe-based
Laser-based
Others

By Application

Medical (Tissue And Organ Generation, Medical Pills, Prosthetics And Implants, Others)
Dental
Biosensors
Consumer/Personal Product Testing
Bioinks
Food And Animal Product

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the 3D Bioprinting market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the 3D Bioprinting market include Envisiontec Inc., Organovo Holdings Inc., Inventia Life Science PTY LTD, Poietis, Vivax Bio LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Regemat 3D S.L. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . 3D BIOPRINTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 By Technology
- 3.7.2 By Application
- 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL 3D BIOPRINTING MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Magnetic Levitation Market by Regions
6.6 Inkjet-based Market by Regions
6.5 Syringe-based Market by Regions
6.7 Laser-based Market by Regions
6.8 Others Market by Regions

7 . GLOBAL 3D BIOPRINTING MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Medical Market by Regions
7.5 Dental Market by Regions
7.6 Biosensors Market by Regions
7.7 Consumer/Personal Product Testing Market by Regions
7.8 Bioinks Market by Regions
7.9 Food and Animal Product Market by Regions

8 . GLOBAL 3D BIOPRINTING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America
- 8.3.1. Overview, Historic and Forecast Data
- 8.3.2. North America By Segment
- 8.3.3. North America By Country
- 8.3.4. United State
- 8.3.5. Canada
- 8.3.6. Mexico
8.4. Europe
- 8.4.1. Overview, Historic and Forecast Data
- 8.4.2. Europe by Segment
- 8.4.3. Europe by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7. Italy
- 8.4.8. Russia
- 8.4.9. Rest Of Europe
8.5. Asia Pacific
- 8.5.1. Overview, Historic and Forecast Data
- 8.5.2. Asia Pacific by Segment
- 8.5.3. Asia Pacific by Country
- 8.5.4. China
- 8.5.5. India
- 8.5.6. Japan
- 8.5.7. South Korea
- 8.5.8. Australia
- 8.5.9. Rest Of Asia Pacific
8.6. Latin America
- 8.6.1. Overview, Historic and Forecast Data
- 8.6.2. Latin America by Segment
- 8.6.3. Latin America by Country
- 8.6.4. Brazil
- 8.6.5. Argentina
- 8.6.6. Peru
- 8.6.7. Chile
- 8.6.8. Rest of Latin America
8.7. Middle East & Africa
- 8.7.1. Overview, Historic and Forecast Data
- 8.7.2. Middle East & Africa by Segment
- 8.7.3. Middle East & Africa by Country
- 8.7.4. Saudi Arabia
- 8.7.5. UAE
- 8.7.6. Israel
- 8.7.7. South Africa
- 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE 3D BIOPRINTING COMPANIES

9.1. 3D Bioprinting Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF 3D BIOPRINTING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Envisiontec, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Inventia Life Science PTY LTD
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Organovo Holdings, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Vivax Bio
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. LLC
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. 3D Bioprinting Solutions
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Regemat 3D S.L.
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Poietis
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. AlleviCyfuse Biomedical K.K.
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Cellink Global
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments